The management expects the impact of COVID-19 to be short-lived and has guided for a recovery in the near term.from Stocks-Markets-Economic Times https://ift.tt/3fhD8aI
Buy Cipla, target price Rs 650: Sharekhan
The management expects the impact of COVID-19 to be short-lived and has guided for a recovery in the near term.from Stocks-Markets-Economic Times https://ift.tt/3fhD8aI
Related Posts:
At FMCG companies, production crosses pre-Covid for food & hygiene goods- SBI moves NCLT to recover Rs 1.2k-cr Reliance Communications loans
- Stocks in the news: Vodafone Idea, SBI, M&M, Eicher Motors, Hindalco and IDFC
- RBI plans to overhaul corporate governance structure of banks
- Carlyle leads race for Piramal pharma stake
0 Comments:
Post a Comment